What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Tablet & Capsules

STEPROG-200 SR TAB

Natural Progestrone-200mg

Pack: 10x10
Format: Alu-Alu

MRP₹2,650.00

A high-potency, bio-identical hormonal supplement formulated for the intensive management of progesterone deficiencies and the maintenance of early pregnancy. STEPROG-200 SR contains 200mg of Natural Micronized Progesterone in a Sustained-Release (SR) delivery system, designed to provide a steady therapeutic effect and support endometrial health.

About The Product

Key Benefits

Bio-Identical Hormonal Replacement

STEPROG-200 SR utilizes natural micronized progesterone, which is chemically identical to the hormone produced by the human ovary. This ensures high biological compatibility and effective binding to progesterone receptors, providing a more natural physiological response compared to synthetic progestins.

Advanced Sustained-Release Technology

The SR formulation is engineered to release the hormone gradually into the bloodstream over an extended period. This maintains stable plasma concentrations, prevents the "peaks and valleys" associated with conventional tablets, and reduces the incidence of side effects like dizziness or drowsiness.

Support for High-Risk Pregnancy

This medication is a cornerstone in the management of threatened and recurrent miscarriages. By ensuring the secretory transformation of the endometrium, it creates a stable and receptive uterine environment necessary for the successful implantation and maintenance of the embryo.

Management of Menstrual Irregularities

STEPROG-200 SR is highly effective in treating secondary amenorrhea and dysfunctional uterine bleeding. It regulates the shedding of the uterine lining, helping to restore a normal menstrual rhythm and preventing endometrial hyperplasia caused by unopposed estrogen.

Luteal Phase Support in ART

In Assisted Reproductive Technology (ART) and IVF cycles, this formulation provides essential luteal phase support. It compensates for the body’s insufficient natural progesterone production, significantly increasing the chances of a sustained clinical pregnancy.

Endometrial Protection in HRT

When used as part of Hormone Replacement Therapy (HRT) for menopausal women, natural progesterone protects the uterus from the overgrowth of the lining. It effectively balances estrogen therapy, reducing the risk of endometrial complications while managing menopausal symptoms.

Indication Maintenance of Threatened or Recurrent Pregnancy, Luteal Phase Support in Infertility/IVF, Secondary Amenorrhea, Dysfunctional Uterine Bleeding, Premenstrual Syndrome (PMS), Component of Menopausal Hormone Therapy.

Indications

Maintenance of Threatened or Recurrent Pregnancy
Luteal Phase Support in Infertility/IVF
Secondary Amenorrhea
Dysfunctional Uterine Bleeding
Premenstrual Syndrome (PMS)
Component of Menopausal Hormone Therapy.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

STEPROG-200 SR TAB